Event Detail

Baltimore, MD—Womble Carlyle is proud to be a Silver Sponsor of “Drug Discovery in Academia” conference presented by Johns Hopkins Brain Science Institute. Over the last several years, a new business model has emerged in drug discovery. Leaders from industry, academia and funding centers will discuss the opportunities, challenges and risks. Attendees will address best practices in forging successful partnerships between academia and industry. The day-long conference will take place on Tuesday, October 18, 2011, at the Baltimore Convention Center. For more information and to register, please click here.

 

Womble Carlyle is a full-service business law firm that provides a wide-ranging array of services that life science companies need in order to be successful. Our clients are varied and cover the continuum from university spin-offs and venture capital-backed start-ups to Fortune 100 multi-national corporations. Our Life Sciences Industry Group, a multi-disciplinary team, focuses primarily on three industry segments — pharmaceutical and animal health; biotechnology; and medical devices.

 

The experience of the firm’s Intellectual Property lawyers extends to all aspects of domestic and foreign intellectual property law. Our life science patent lawyers bring decades of combined field experience as engineers and scientists to their life science legal work. Our lawyers are experienced in preparing and prosecuting patent applications relating to complex pharmaceutical compounds, nucleic acids, proteins, peptides, antibodies, transgene technology, transgenic animals and plants, nucleic acid expression systems, and gene therapy. For more information please visit www.wcsr.com/lifesciences.